LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST)

Historical Holders from Q2 2021 to Q3 2025

Symbol: LFST on Nasdaq
Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 388,917,807
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 349,969,099
Holdings value: $1,924,816,425
% of all portfolios: 0%
Number of holders: 207
Number of buys: 128
Number of sells: -95
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	10.1%	+1%	$215,869,797	+$2,223,639	39,249,054	+1%	FMR LLC	31 Oct 2025
SUMMIT PARTNERS L P	8.62%		$184,385,932		33,524,715		Summit Partners, L.P.	30 Sep 2025

Institutional Holders of LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	349,969,099	$1,924,816,425	+$2,242,808	$3,860,450	$5,786,846	$5.5	207
2025 Q2	349,211,507	$1,805,446,226	+$26,470,202	$4,231,007	$7,009,922	$5.17	193
2025 Q1	343,293,098	$2,286,399,131	+$28,506,338	$7,925,496	$12,260,020	$6.66	180
2024 Q4	336,632,306	$2,481,009,214	+$57,920,008	$7,007,234	$40,448,966	$7.37	152
2024 Q3	328,987,104	$2,302,787,638	+$385,503	$7,573,396	$19,484,592	$7	129
2024 Q2	327,111,787	$1,606,123,781	+$26,316,859	$3,973,172	$2,258,118	$4.91	130
2024 Q1	321,255,679	$1,982,331,016	+$72,312,533	$7,694,607	$2,406,183	$6.17	123
2023 Q4	309,497,893	$2,423,368,969	+$91,163,728	$1,876,851	$1,346,760	$7.83	118
2023 Q3	298,420,193	$2,050,146,379	+$48,948,530	$1,922,226	$922,641	$6.87	117
2023 Q2	290,988,403	$2,656,744,574	+$31,775,791	$1,500,059	$568,799	$9.13	109
2023 Q1	287,568,675	$2,136,617,078	+$2,802,644	$734,084	$179,063	$7.43	86
2022 Q4	287,897,858	$1,422,185,198	-$5,682,633	$64,220	$74,594	$4.94	84
2022 Q3	288,807,286	$1,911,997,521	-$30,576,662	$148,000	$134,000	$6.62	72
2022 Q2	294,731,958	$1,638,707,002	+$20,710,430	$132,000	$141,000	$5.56	76
2022 Q1	290,691,955	$2,938,605,431	+$156,460,286	$136,000	$485,000	$10.11	72
2021 Q4	275,145,168	$2,619,339,115	-$24,317,438	$297,000	$878,000	$9.52	62
2021 Q3	275,121,437	$3,989,223,790	-$38,569,110	$858,000	$4,325,000	$14.5	68
2021 Q2	270,204,603	$7,528,083,656	+$7,528,083,616			$27.86	81